Xponance, Inc. Incyte Corp Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Xponance, Inc. holds 23,148 shares of INCY stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,148

Previous 26,199 11.65%

Holding current value

$1.61 Million

Previous $1.59 Million 3.65%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$57.33 - $68.61 $174,913 - $209,329	-3,051 Reduced 11.65%	23,148 $1.53 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $609,502 - $759,198	-11,909 Reduced 31.25%	26,199 $1.59 Million
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $104,843 - $123,457	1,854 Added 5.11%	38,108 $2.17 Million
Q4 2023 Jan 31, 2024	SELL	$52.16 - $64.19 $173,275 - $213,239	-3,322 Reduced 8.39%	36,254 $2.28 Million
Q3 2023 Oct 23, 2023	BUY	$57.77 - $65.93 $38,532 - $43,975	667 Added 1.71%	39,576 $2.29 Million
Q2 2023 Jul 13, 2023	SELL	$60.95 - $75.51 $66,679 - $82,607	-1,094 Reduced 2.73%	38,909 $2.42 Million
Q1 2023 Apr 17, 2023	BUY	$70.23 - $86.01 $74,233 - $90,912	1,057 Added 2.71%	40,003 $2.89 Million
Q4 2022 Jan 23, 2023	BUY	$67.18 - $84.11 $204,899 - $256,535	3,050 Added 8.5%	38,946 $0
Q3 2022 Oct 24, 2022	BUY	$66.18 - $82.86 $179,877 - $225,213	2,718 Added 8.19%	35,896 $2.39 Million
Q2 2022 Aug 02, 2022	BUY	$66.18 - $83.18 $317,994 - $399,679	4,805 Added 16.94%	33,178 $2.52 Million
Q1 2022 Apr 20, 2022	BUY	$66.02 - $79.71 $28,124 - $33,956	426 Added 1.52%	28,373 $2.25 Million
Q4 2021 Jan 31, 2022	BUY	$63.34 - $74.11 $126,870 - $148,442	2,003 Added 7.72%	27,947 $2.05 Million
Q3 2021 Nov 05, 2021	SELL	$68.67 - $84.02 $45,528 - $55,705	-663 Reduced 2.49%	25,944 $1.78 Million
Q2 2021 Aug 12, 2021	SELL	$79.87 - $87.53 $49,120 - $53,830	-615 Reduced 2.26%	26,607 $2.24 Million
Q1 2021 May 10, 2021	BUY	$76.02 - $100.5 $14,595 - $19,296	192 Added 0.71%	27,222 $2.21 Million
Q4 2020 Feb 11, 2021	BUY	$80.74 - $97.7 $44,972 - $54,418	557 Added 2.1%	27,030 $2.35 Million
Q3 2020 Oct 26, 2020	BUY	$85.07 - $109.69 $25,776 - $33,236	303 Added 1.16%	26,473 $2.38 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $1.94 Million - $2.85 Million	26,170 New	26,170 $2.72 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account